Clinical Trial Update: Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the combination of docetaxel and gemcitabine for platinum-resistant ovarian cancer and primary peritoneal carcinoma; results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: University of Southern California | Conditions: Ovarian Carcinoma, Peritoneal Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2013-01-25